Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04608305
What this trial is testing

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

Who this might be right for
Covid19
Israel Institute for Biological Research (IIBR) 843
Testing effectiveness (Phase 2)UnknownNCT05185817
What this trial is testing

Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)COVID-19 VaccinesImmune System Tolerance
Tehran University of Medical Sciences 100
Large-scale testing (Phase 3)Study completedNCT04655625
What this trial is testing

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Who this might be right for
COVID-19
AnGes, Inc. 500
Not applicableUnknownNCT04845997
What this trial is testing

COVID-19 Vaccination in Patients With Rheumatic Diseases

Who this might be right for
Rheumatic Diseases
Sociedad Argentina de Reumatologia 3,000
Not applicableStudy completedNCT05096260
What this trial is testing

Getting to Yes, Michigan! (G2YMI)

Who this might be right for
COVID-19 VaccinesCOVID-19 Pandemic
University of Michigan 1,180
Early research (Phase 1)Study completedNCT06441968
What this trial is testing

Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT04992260
What this trial is testing

Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 11,349
Not applicableActive Not RecruitingNCT05869968
What this trial is testing

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

Who this might be right for
Spinal Cord InjuriesTraumatic Spinal Cord InjuryHealthy Controls+2 more
Northwell Health 140
Testing effectiveness (Phase 2)Looking for participantsNCT06381739
What this trial is testing

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

Who this might be right for
COVID-19 Infection
McMaster University 350
Testing effectiveness (Phase 2)Study completedNCT06436911
What this trial is testing

To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA

Who this might be right for
COVID-19
Entos Pharmaceuticals Inc. 46
Testing effectiveness (Phase 2)Study completedNCT04889209
What this trial is testing

Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 867
Testing effectiveness (Phase 2)Study completedNCT04869592
What this trial is testing

A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

Who this might be right for
COVID-19
National Vaccine and Serum Institute, China 3,100
Early research (Phase 1)Looking for participantsNCT06355232
What this trial is testing

Covid-19 and Influenza Oral Vaccine Study

Who this might be right for
covid19 InfectionInfluenza, Human
Vaxine Pty Ltd 100
Post-approval studies (Phase 4)Study completedNCT04869358
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT04664309
What this trial is testing

Understanding Immunity to the COVID-19 Vaccines

Who this might be right for
COVID-19ImmunityVaccine
Stanford University 43
Large-scale testing (Phase 3)Study completedNCT05567471
What this trial is testing

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

Who this might be right for
COVID-19 Respiratory Infection
Bharat Biotech International Limited 875
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Not applicableUnknownNCT05042011
What this trial is testing

Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study

Who this might be right for
mHealthSocial MediaVaccine Hesitancy+1 more
Aga Khan University 80
Not applicableStudy completedNCT06646406
What this trial is testing

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Who this might be right for
COVID-19 ImmunisationInfluenza Vaccine
Mayo Clinic 114,165
Post-approval studies (Phase 4)UnknownNCT05329064
What this trial is testing

Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children

Who this might be right for
Vaccine ReactionCOVID-19Children, Only
KK Women's and Children's Hospital 150
Next Page